These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 12520462)

  • 1. Modulation of cell death in the tumor microenvironment.
    Wouters BG; Koritzinsky M; Chiu RK; Theys J; Buijsen J; Lambin P
    Semin Radiat Oncol; 2003 Jan; 13(1):31-41. PubMed ID: 12520462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
    Chung LW; Baseman A; Assikis V; Zhau HE
    J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vascular endothelial growth factor gene expression in nasopharyngeal carcinoma cell line induced by hypoxia in vitro].
    Yang HF; Tang WP
    Ai Zheng; 2003 Feb; 22(2):160-3. PubMed ID: 12600291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proangiogenic role of tumor-activated hepatic stellate cells in experimental melanoma metastasis.
    Olaso E; Salado C; Egilegor E; Gutierrez V; Santisteban A; Sancho-Bru P; Friedman SL; Vidal-Vanaclocha F
    Hepatology; 2003 Mar; 37(3):674-85. PubMed ID: 12601365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of hypoxia-related gene expression in sarcomas and effect of hypoxia on RNA interference of vascular endothelial cell growth factor A.
    Detwiller KY; Fernando NT; Segal NH; Ryeom SW; D'Amore PA; Yoon SS
    Cancer Res; 2005 Jul; 65(13):5881-9. PubMed ID: 15994966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biology of angiogenesis in tumors of the gastrointestinal tract.
    Reinmuth N; Parikh AA; Ahmad SA; Liu W; Stoeltzing O; Fan F; Takeda A; Akagi M; Ellis LM
    Microsc Res Tech; 2003 Feb; 60(2):199-207. PubMed ID: 12539174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: exploring mechanisms of interaction.
    Wachsberger P; Burd R; Dicker AP
    Clin Cancer Res; 2003 Jun; 9(6):1957-71. PubMed ID: 12796357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypoxia and angiogenesis].
    Simon JM
    Bull Cancer; 2007 Jul; 94 Spec No():S160-5. PubMed ID: 17846000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mechanisms and role of lymphangiogenesis in cancer metastasis].
    Dupuy E; Tobelem G
    Bull Cancer; 2003 Jul; 90(7):595-9. PubMed ID: 12957800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of hypoxia-induced factors in tumor progression.
    Vaupel P
    Oncologist; 2004; 9 Suppl 5():10-7. PubMed ID: 15591418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia selects for high-metastatic Lewis lung carcinoma cells overexpressing Mcl-1 and exhibiting reduced apoptotic potential in solid tumors.
    Koshikawa N; Maejima C; Miyazaki K; Nakagawara A; Takenaga K
    Oncogene; 2006 Feb; 25(6):917-28. PubMed ID: 16247470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HER-2/neu overexpression increases the viable hypoxic cell population within solid tumors without causing changes in tumor vascularization.
    Dragowska WH; Warburton C; Yapp DT; Minchinton AI; Hu Y; Waterhouse DN; Gelmon K; Skov K; Woo J; Masin D; Huxham LA; Kyle AH; Bally MB
    Mol Cancer Res; 2004 Nov; 2(11):606-19. PubMed ID: 15561777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-induced changes in the expression of VEGF, HIF-1 alpha and cell cycle-related molecules in ovarian cancer cells.
    Horiuchi A; Imai T; Shimizu M; Oka K; Wang C; Nikaido T; Konishi I
    Anticancer Res; 2002; 22(5):2697-702. PubMed ID: 12529984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor hypoxia and cancer progression.
    Zhou J; Schmid T; Schnitzer S; Brüne B
    Cancer Lett; 2006 Jun; 237(1):10-21. PubMed ID: 16002209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute and chronic in vivo therapeutic resistance.
    Teicher BA
    Biochem Pharmacol; 2009 Jun; 77(11):1665-73. PubMed ID: 19428320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of hypoxia-inducible factor 2alpha in renal cell carcinoma associated with loss of Tsc-2 tumor suppressor gene.
    Liu MY; Poellinger L; Walker CL
    Cancer Res; 2003 May; 63(10):2675-80. PubMed ID: 12750296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constitutive and inducible expression and regulation of vascular endothelial growth factor.
    Xie K; Wei D; Shi Q; Huang S
    Cytokine Growth Factor Rev; 2004 Oct; 15(5):297-324. PubMed ID: 15450248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of tumor oxygenation and their influence on the cellular hypoxic response and hypoxia-directed therapies.
    Magagnin MG; Koritzinsky M; Wouters BG
    Drug Resist Updat; 2006; 9(4-5):185-97. PubMed ID: 16926105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of HIF-1 alpha and VEGF expression by the chemopreventive bioflavonoid apigenin is accompanied by Akt inhibition in human prostate carcinoma PC3-M cells.
    Mirzoeva S; Kim ND; Chiu K; Franzen CA; Bergan RC; Pelling JC
    Mol Carcinog; 2008 Sep; 47(9):686-700. PubMed ID: 18240292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hypoxic tumor microenvironment and gene expression.
    Leo C; Giaccia AJ; Denko NC
    Semin Radiat Oncol; 2004 Jul; 14(3):207-14. PubMed ID: 15254863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.